Overexpression or somatic mutation of EGFR causes the aberrant activation of its tyrosine kinase and the dysregulation of its downstream signals that contribute to the tumor growth and progression and the poor prognosis of NSCLC patients [3]. Here, EGFR is linked to neoplasm.